Data published in PLoS One suggests adults who have used marijuana face a lower risk of suffering from non-alcoholic fatty liver disease (NAFLD) than those who have not. Using a samily size of 22,000 adults, researchers from Stanford University in California and Seoul National University College of Medicine in South Korea assessed the relationship between marijuana use and NAFLD, and found cannabis use independently predicted lower risks of the condition, and that the effect was dose-dependent. This information supports the findings from previous studies. Researchers concluded, “Active marijuana use provided a protective effect against NAFLD independent of known metabolic risk factors… [W]e conclude that current marijuana use may favorably impact the pathogenesis of NAFLD in US adults.”
This information has been provided by NORML and approved by our Chief Medical Officer.